Symbol="KYMR"
AssetType="Common Stock"
Name="Kymera Therapeutics Inc"
Description="Kymera Therapeutics, Inc., a biopharmaceutical company, is focused on discovering and developing new small molecule treatments that selectively break down disease-causing proteins by harnessing the body's own natural protein breakdown system. The company is headquartered in Watertown, Massachusetts."
CIK="1815442"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="300 TECHNOLOGY SQUARE, 2ND FLOOR, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1196861000"
EBITDA="-167680000"
PERatio="None"
PEGRatio="None"
BookValue="8.43"
DividendPerShare="0"
DividendYield="0"
EPS="-2.77"
RevenuePerShareTTM="0.84"
ProfitMargin="0"
OperatingMarginTTM="-3.635"
ReturnOnAssetsTTM="-0.18"
ReturnOnEquityTTM="-0.357"
RevenueTTM="46670000"
GrossProfitTTM="-117422000"
DilutedEPSTTM="-2.77"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.016"
AnalystTargetPrice="53.72"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="33.3"
PriceToBookRatio="3.168"
EVToRevenue="25.24"
EVToEBITDA="-7.69"
Beta="1.51"
num_52WeekHigh="39.85"
num_52WeekLow="18.84"
num_50DayMovingAverage="25.43"
num_200DayMovingAverage="28.74"
SharesOutstanding="55308000"
DividendDate="None"
ExDividendDate="None"
symbol="KYMR"
open="21.59"
high="21.94"
low="21.24"
price="21.90"
volume="278809.00"
latest_trading_day="2023-07-24"
previous_close="21.64"
change="0.26"
change_percent="1.2015%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="73"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="27"
Volume_recent_avg="487686"
Change_recent_avg="-0.08"
Delta_recent_avg="1.47"
Variance_recent_avg="0.73"
Change_ratio_recent_avg="-0.37"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="27"
Aroon_momentum_negative="73"
image_negative_thumbnail_id_1="95"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0081.jpeg"
image_negative_thumbnail_id_2="94"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0082.jpeg"
image_neutral_thumbnail_id_1="592"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0007.jpeg"
image_neutral_thumbnail_id_2="568"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0031.jpeg"
image_positive_thumbnail_id_1="695"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0013.jpeg"
image_positive_thumbnail_id_2="623"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0085.jpeg"
image_professor_thumbnail_id_1="1175"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0009.jpeg"
image_professor_thumbnail_id_2="1189"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0023.jpeg"
